JENBURKT PHARMACEUTICALS LTD.

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
INCOME :
Sales Turnover	122.64	114.99	104.92	94.94	86.53
Other Income	3.41	3.39	2.96	2.74	2.1
Stock Adjustments	2.49	-3.48	1.95	1.21	0.65
Total Income	128.54	114.9	109.83	98.89	89.28
EXPENDITURE :
Raw Materials	38.75	30.51	32.51	28.89	26.58
Excise Duty	0	0.32	1.61	1.36	1.32
Power and Fuel Cost	0.59	0.61	0.53	0.57	0.52
Other Manufacturing Expenses	1.23	0.84	0.4	1.28	1.22
Employee Cost	31.2	27.69	25.21	21.49	18.99
Selling and Administration Expenses	28.09	27.3	26.61	26.11	23.29
Miscellaneous Expenses	0.32	0.45	0.28	0	0
Less: Preoperative Expenditure Capitalised	0	0	0	0	0
Profit before Interest, Depreciation and Tax	28.38	27.18	22.68	19.2	17.36
Interest and Financial Charges	0.39	0.41	0.41	0.38	0.36
Profit before Depreciation and Tax	27.99	26.77	22.27	18.82	17
Depreciation	1.35	1.5	1.79	1.99	2.66
Profit Before Tax	26.64	25.27	20.48	16.83	14.34
Tax	6.84	8.06	6.97	6.05	4.69
Profit After Tax	19.8	17.21	13.51	10.78	9.65
Adjustment below Net Profit	-0.57	-4.5	0	0	0.01
P and L Balance brought forward	53.27	45.7	32.19	25.44	19.31
Appropriations	3.09	5.14	0	4.03	3.53
P and L Bal. carried down	69.42	53.27	45.7	32.19	25.44
Equity Dividend	2.75	5.14	0	3.35	2.93
Preference Dividend	0	0	0	0	0
Corporate Dividend Tax	0	0	0	0.68	0.6
Equity Dividend (%)	102	60	81	72	63
Earning Per Share (Rs.)	43.14	37.5	29.05	21.72	19.47
Book Value	168.79	133.48	117.09	86.44	71.92
Extraordinary Items	-0.02	0.03	0.08	0	0.02

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

INCOME :

Sales Turnover

122.64

114.99

104.92

94.94

86.53

Other Income

3.41

3.39

2.96

2.74

2.1

Stock Adjustments

2.49

-3.48

1.95

1.21

0.65

Total Income

128.54

114.9

109.83

98.89

89.28

EXPENDITURE :

Raw Materials

38.75

30.51

32.51

28.89

26.58

Excise Duty

0.32

1.61

1.36

1.32

Power and Fuel Cost

0.59

0.61

0.53

0.57

0.52

Other Manufacturing Expenses

1.23

0.84

0.4

1.28

1.22

Employee Cost

31.2

27.69

25.21

21.49

18.99

Selling and Administration Expenses

28.09

27.3

26.61

26.11

23.29

Miscellaneous Expenses

0.32

0.45

0.28

Less: Preoperative Expenditure Capitalised

Profit before Interest, Depreciation and Tax

28.38

27.18

22.68

19.2

17.36

Interest and Financial Charges

0.39

0.41

0.38

0.36

Profit before Depreciation and Tax

27.99

26.77

22.27

18.82

Depreciation

1.35

1.5

1.79

1.99

2.66

Profit Before Tax

26.64

25.27

20.48

16.83

14.34

Tax

6.84

8.06

6.97

6.05

4.69

Profit After Tax

19.8

17.21

13.51

10.78

9.65

Adjustment below Net Profit

-0.57

-4.5

0.01

P and L Balance brought forward

53.27

45.7

32.19

25.44

19.31

Appropriations

3.09

5.14

4.03

3.53

P and L Bal. carried down

69.42

53.27

45.7

32.19

25.44

Equity Dividend

2.75

5.14

3.35

2.93

Preference Dividend

Corporate Dividend Tax

0.68

0.6

Equity Dividend (%)

102

Earning Per Share (Rs.)

43.14

37.5

29.05

21.72

19.47

Book Value

168.79

133.48

117.09

86.44

71.92

Extraordinary Items

-0.02

0.03

0.08

0.02

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
SOURCES OF FUNDS :
Share Capital	4.59	4.59	4.65	4.65	4.65
Reserves and Surplus	72.88	56.67	49.79	35.54	28.79
Total Shareholders Funds	77.47	61.26	54.44	40.19	33.44
Secured Loans	0	0.24	0.24	5.42	6.63
Unsecured Loans	10.21	2.79	9.06	2.88	2.69
Total Debt	10.21	3.03	9.3	8.3	9.32
Total Liabilities	87.68	64.29	63.74	48.49	42.76
APPLICATION OF FUNDS :
Gross Block	26.89	25.69	25.45	25.54	23.49
Less: Accum. Depreciation	17.3	16.12	14.83	13.44	11.88
Net Block	9.59	9.57	10.62	12.1	11.61
Capital Work in Progress	0.99	0	0	0	0
Investments	5.38	5.42	1.94	0.61	0.31
Current Assets, Loans and Advances
Inventories	9.83	6.8	10.75	8.24	7.58
Sundry Debtors	22.89	12.54	9.07	5.78	7.38
Cash and Bank Balance	51.7	41.11	42.08	29.64	27.51
Loans and Advances	2.56	2.42	2.07	1.79	6.46
Less: Current Liab. and Prov.
Current Liabilities	14.71	13.29	12.09	8.74	9.36
Provisions	0.55	0.27	0.7	0.93	8.72
Net Current Assets	71.72	49.31	51.18	35.78	30.85
Miscellaneous Expenses not w/o	0	0	0	0	0
Total Assets	87.68	64.3	63.74	48.49	42.77
Contingent Liabilities	16.58	16.61	16.59	0.07	3.33

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

SOURCES OF FUNDS :

Share Capital

4.59

4.65

Reserves and Surplus

72.88

56.67

49.79

35.54

28.79

Total Shareholders Funds

77.47

61.26

54.44

40.19

33.44

Secured Loans

0.24

5.42

6.63

Unsecured Loans

10.21

2.79

9.06

2.88

2.69

Total Debt

10.21

3.03

9.3

8.3

9.32

Total Liabilities

87.68

64.29

63.74

48.49

42.76

APPLICATION OF FUNDS :

Gross Block

26.89

25.69

25.45

25.54

23.49

Less: Accum. Depreciation

17.3

16.12

14.83

13.44

11.88

Net Block

9.59

9.57

10.62

12.1

11.61

Capital Work in Progress

0.99

Investments

5.38

5.42

1.94

0.61

0.31

Current Assets, Loans and Advances

Inventories

9.83

6.8

10.75

8.24

7.58

Sundry Debtors

22.89

12.54

9.07

5.78

7.38

Cash and Bank Balance

51.7

41.11

42.08

29.64

27.51

Loans and Advances

2.56

2.42

2.07

1.79

6.46

Less: Current Liab. and Prov.

Current Liabilities

14.71

13.29

12.09

8.74

9.36

Provisions

0.55

0.27

0.7

0.93

8.72

Net Current Assets

71.72

49.31

51.18

35.78

30.85

Miscellaneous Expenses not w/o

Total Assets

87.68

64.3

63.74

48.49

42.77

Contingent Liabilities

16.58

16.61

16.59

0.07

3.33

JENBURKT PHARMACEUTICALS LTD.

Enjoy Lifetime Free Delivery Trade